Mary Kariuki opted for a five-year contraceptive implant to avoid an unplanned pregnancy. However, what was intended to provide her with peace of mind became a source of distress when she started to experience heavy bleeding almost every week.
The frequent bleeding eventually led her to abandon contraceptives altogether. ‘I could hardly go a week without bleeding. The implant was the last method I decided to try after the one I had trusted failed me,’ said Ms Kariuki.
The 2025-26 Kenya Mini Demographic and Health Survey shows that 99 percent of currently married women aged 15 to 49 know at least one modern contraceptive method.
‘The most well-known methods among currently married women are injectables (98 percent), implants (97 percent), male condoms (96 percent) and pills (95 percent), while the Standard Days Method is the least well-known modern contraceptive method (46 percent). On average, currently married women are aware of 10 contraceptive methods,’ the report stated.
Despite this knowledge, 28 percent of contraceptive-use episodes recorded in the five years before the survey were discontinued within 12 months.
“The main reasons for discontinuation were the desire to become pregnant (25 percent) and side effects or health concerns (24 percent),” said the report.
The discontinuation rate was higher for short-term methods, reaching 38 percent for contraceptive pills, 37 percent for injectables, and 36 percent for male condoms.
Vincent Nyangweso, a general practitioner, says that discontinuation for reasons other than the desire to become pregnant is a public health concern because it is associated with negative reproductive health outcomes.
‘Contraceptive discontinuation contributes to higher fertility rates, unwanted pregnancies and abortions, which hurt maternal, neonatal and child health outcomes,’ Dr Nyangweso said.
For the contraceptive market, the figures indicate a mismatch between awareness and sustained use. Women may be aware of the available methods, but they may still stop using them due to side effects, cost, poor counselling, or difficulty obtaining their preferred method.
Around 55 percent of women using modern contraceptives said they had received all three key pieces of information, including details of possible side effects, what to do if they experienced them, and alternative methods they could use.
The gap was wider in the private sector, where only 42 percent of users received all three elements, compared with 60 percent of those who obtained their methods from public facilities.
According to Dr Nyangweso, experiencing side effects does not necessarily mean a woman has to stop using contraception.
‘She may need medical attention, reassurance, or a different method. But without proper counselling, some women may stop using contraception without finding an alternative,’ he said.
The Ministry of Health introduced a ‘Counselling for Continuation’ approach in its 2025 National Family Planning Guidelines, which emphasises helping clients to manage side effects, understand their options, and switch methods when necessary.
Speaking at the World Contraception Day celebrations, the Ministry of Health’s Director of Curative and Nursing Services, Andrew Toro, said healthcare workers needed to give clients enough time and accurate information to choose a method.
‘Take time with them, go through the methods, ask questions, talk about adverse reactions and make sure you inform them,’ said Dr Toro.
Availability remains another problem. Nelly Munyasia, executive director of Reproductive Health Network Kenya (RHNK), warned that shortages of preferred short-term methods were leaving women with fewer choices.
In an earlier interview with the Nation, Millicent Navinywa, a healthcare provider in Kilifi, described the difficulty of turning away women who could not afford to buy contraceptives from private providers when public facilities ran out of stock.
‘I feel bad having to send women to buy contraceptives when they can’t afford it. The only option I can offer is a five-year non-hormonal implant, but most women prefer short-term methods, which I don’t have,’ she said.
The shortages are particularly significant in a market where women obtain different methods from different sources. The latest survey shows that private medical providers supply 66 percent of contraceptive pills and 64 percent of male condoms.
The public sector is the main source of implants (88 percent) and injectables (65 percent).
For women who cannot find their preferred method at a public facility, buying it privately can be expensive.
At Marie Stopes Kenya’s Meru clinic, for example, the published price list shows an intramuscular injectable costs Sh315, while implants cost between Sh2,500 and Sh3,000. A copper intrauterine device costs Sh3,500, and a hormonal intrauterine device (IUD) costs Sh12,000.
The cost of the method is only one part of the expense. Women may also pay for consultations, transport, and follow-up visits, especially if they experience complications or need to switch methods.
Misinformation can also influence decisions. A 2018 study published in Studies in Family Planning documented beliefs in three rural Kenyan coastal communities that using modern contraception before a first birth or at a young age could cause infertility.
This belief is particularly difficult to address in communities where having children is closely tied to marriage and social acceptance.
Women who experience difficulty conceiving after using contraception may be seen as proof that the methods cause infertility, despite there being no medical evidence to link the two.
‘Such fears can discourage women from starting to use contraception, or cause them to stop,’ said Dr Nyangweso.